Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lisa Landrum
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Oct 2011
- Primary completion
- 8 Jun 2016
- Completion
- 11 Feb 2017
- Last update posted
- 22 Jul 2019
- Registered enrollment
- 41
- Registry id
- NCT01459380
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.